The identification of transcription factors, including MYC, TP53, and SP1, associated with genes negatively correlating with TSPAN32 provides additional data about the regulatory mechanisms governing TSPAN32 expression in BL. The gene discussed is MYC; the disease is Burkitt lymphoma.